Diagnostic and Prognostic Predictive Value of Serum Selenium and Redox Biomarkers in Retinal Vein Occlusion.

IF 2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
International Journal of General Medicine Pub Date : 2025-09-19 eCollection Date: 2025-01-01 DOI:10.2147/IJGM.S522918
Danqing Shen, Meixiu Li, Wencai Sun, Zhifu Tao
{"title":"Diagnostic and Prognostic Predictive Value of Serum Selenium and Redox Biomarkers in Retinal Vein Occlusion.","authors":"Danqing Shen, Meixiu Li, Wencai Sun, Zhifu Tao","doi":"10.2147/IJGM.S522918","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the diagnostic efficacy and prognostic predictive value of serum selenium (Sse) and redox biomarkers in retinal vein occlusion (RVO).</p><p><strong>Methods: </strong>A prospective analysis was conducted on 112 RVO patients (RVO Group) admitted to the hospital between January 2022 and February 2024, along with 112 non-RVO ophthalmic patients (non-RVO Group) during the same period. The levels of Sse and redox factors [high mobility group protein B1 (HMGB1), reduced glutathione (GSH), nitric oxide (NO), and superoxide dismutase (SOD)] were compared between the two groups, and the receiver operating characteristic (ROC) curves were plotted to analyze their diagnostic efficacy for RVO. The RVO Group received treatment and was divided into poor prognosis group and good prognosis group based on prognosis. The changes in Sse and redox biomarker levels were compared to analyze factors influencing RVO patient prognosis, and a nomogram was constructed to validate the calibration curve.</p><p><strong>Results: </strong>Compared with the non-RVO group, the levels of Sse, GSH, and SOD were lower, while the levels of HMGB1 and NO were higher in the RVO group (<i>P</i> <0.05). The ROC curve showed that Sse and various oxidative stress factors had good diagnostic efficacy for RVO. In the Poor Prognosis Group, Sse, GSH, NO, and SOD levels were lower than those in the Good Prognosis Group, while HMGB1 levels were higher than those in the Good Prognosis Group (<i>P</i> <0.05). Cox regression analysis showed that all these indicators were factors influencing the prognosis of RVO patients (all P < 0.05). Additionally, the consistency of theroc curves constructed using these factors was good, and the calibration curves were close to the ideal curve.</p><p><strong>Conclusion: </strong>The combined detection of Sse and redox biomarkers can effectively assist in RVO diagnosis, while their dynamic changes have important clinical value in prognosis evaluation.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"18 ","pages":"5731-5742"},"PeriodicalIF":2.0000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12456751/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of General Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJGM.S522918","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To investigate the diagnostic efficacy and prognostic predictive value of serum selenium (Sse) and redox biomarkers in retinal vein occlusion (RVO).

Methods: A prospective analysis was conducted on 112 RVO patients (RVO Group) admitted to the hospital between January 2022 and February 2024, along with 112 non-RVO ophthalmic patients (non-RVO Group) during the same period. The levels of Sse and redox factors [high mobility group protein B1 (HMGB1), reduced glutathione (GSH), nitric oxide (NO), and superoxide dismutase (SOD)] were compared between the two groups, and the receiver operating characteristic (ROC) curves were plotted to analyze their diagnostic efficacy for RVO. The RVO Group received treatment and was divided into poor prognosis group and good prognosis group based on prognosis. The changes in Sse and redox biomarker levels were compared to analyze factors influencing RVO patient prognosis, and a nomogram was constructed to validate the calibration curve.

Results: Compared with the non-RVO group, the levels of Sse, GSH, and SOD were lower, while the levels of HMGB1 and NO were higher in the RVO group (P <0.05). The ROC curve showed that Sse and various oxidative stress factors had good diagnostic efficacy for RVO. In the Poor Prognosis Group, Sse, GSH, NO, and SOD levels were lower than those in the Good Prognosis Group, while HMGB1 levels were higher than those in the Good Prognosis Group (P <0.05). Cox regression analysis showed that all these indicators were factors influencing the prognosis of RVO patients (all P < 0.05). Additionally, the consistency of theroc curves constructed using these factors was good, and the calibration curves were close to the ideal curve.

Conclusion: The combined detection of Sse and redox biomarkers can effectively assist in RVO diagnosis, while their dynamic changes have important clinical value in prognosis evaluation.

Abstract Image

Abstract Image

Abstract Image

血清硒和氧化还原生物标志物对视网膜静脉闭塞的诊断和预后预测价值。
目的:探讨血清硒(Sse)和氧化还原生物标志物对视网膜静脉闭塞(RVO)的诊断效果及预后预测价值。方法:对该院2022年1月至2024年2月收治的112例RVO患者(RVO组)及同期收治的112例非RVO眼科患者(非RVO组)进行前瞻性分析。比较两组患者Sse和氧化还原因子[高迁移率组蛋白B1 (HMGB1)、还原性谷胱甘肽(GSH)、一氧化氮(NO)、超氧化物歧化酶(SOD)]水平,绘制受试者工作特征(ROC)曲线,分析其对RVO的诊断效果。RVO组接受治疗,根据预后情况分为预后差组和预后好组。比较Sse和氧化还原生物标志物水平的变化,分析影响RVO患者预后的因素,并构建nomogram来验证校准曲线。结果:与非RVO组相比,RVO组Sse、GSH、SOD水平较低,HMGB1、NO水平较高(P P)。结论:Sse与氧化还原生物标志物联合检测可有效辅助RVO诊断,其动态变化对预后评价具有重要的临床价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of General Medicine
International Journal of General Medicine Medicine-General Medicine
自引率
0.00%
发文量
1113
审稿时长
16 weeks
期刊介绍: The International Journal of General Medicine is an international, peer-reviewed, open access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treatment protocols. The journal is characterized by the rapid reporting of reviews, original research and clinical studies across all disease areas. A key focus of the journal is the elucidation of disease processes and management protocols resulting in improved outcomes for the patient. Patient perspectives such as satisfaction, quality of life, health literacy and communication and their role in developing new healthcare programs and optimizing clinical outcomes are major areas of interest for the journal. As of 1st April 2019, the International Journal of General Medicine will no longer consider meta-analyses for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信